Viewing Study NCT02081495


Ignite Creation Date: 2025-12-24 @ 2:08 PM
Ignite Modification Date: 2026-02-12 @ 2:19 PM
Study NCT ID: NCT02081495
Status: COMPLETED
Last Update Posted: 2016-11-11
First Post: 2014-03-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoplasms View
None Neoplasms, Ovarian View
None Ovarian Cancer View
None Advanced or Refractory Solid Malignancies View
None Doxorubicin View
None DOXIL View
None CAELYX View